Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· December 10, 2025

Under attack: How AP leaders can stop phony bank account change requests

View original at finance.yahoo.com
Under attack: How AP leaders can stop phony bank account change requests Accounts payable (AP) departments are under siege The frequency, sophistication, and financial impact of payment fraud are accelerating at an unprecedented pace…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • More than $14 billion in cumulative losses attributed to BEC scams in the past five years

    80% confidence
  • Median losses from billing fraud are $140,000 per incident

    80% confidence
  • More than one-third of payment fraud attacks involved phony bank account change requests

    80% confidence
  • 71% of organisations were targeted by payment fraud last year

    80% confidence
  • Fewer than one in three finance employees receive regular anti-fraud education

    80% confidence
  • 58% of AP professionals admit to skipping verification steps at least occasionally due to time constraints

    80% confidence
  • Over 85% of successful payment fraud cases begin with social engineering, not hacking

    80% confidence
  • Only about 40% of global banking systems provide real-time verification

    80% confidence
  • Average loss per payment fraud incident is $125,000 with recovery rates below 20%

    80% confidence
  • Automated verification reduces fraud attempts by more than 60%

    80% confidence
  • 43% increase in phony bank account change attacks over just two years

    80% confidence
  • Median payment-fraud losses are $150,000 per incident

    80% confidence
  • Business email compromise losses totaled more than $3 billion in 2024, a nearly 20% increase from the prior year

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com